NRX Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
NRX Pharmaceuticals, Inc. (NRXP) had Shares Outstanding (Cover Page) of 43.30 million shares as of 2026-08-14, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-14: Entity Common Stock, Shares Outstanding 43.30M shares.
- 2026-05-15: Entity Common Stock, Shares Outstanding 36.23M shares.
- 2026-03-23: Entity Common Stock, Shares Outstanding 33.07M shares.
- 2025-11-13: Entity Common Stock, Shares Outstanding 28.10M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-14 | 43.30M shares 10-Q · filed 2026-08-14 |
| 2026-05-15 | 36.23M shares 10-Q · filed 2026-05-15 |
| 2026-03-23 | 33.07M shares 10-K · filed 2026-03-23 |
| 2025-11-13 | 28.10M shares 10-Q · filed 2025-11-14 |
| 2025-08-14 | 19.71M shares 10-Q · filed 2025-08-18 |
| 2025-05-14 | 17.29M shares 10-Q · filed 2025-05-15 |
| 2025-04-30 | 17.22M shares 10-K/A · filed 2025-04-30 |
| 2025-03-14 | 16.92M shares 10-K · filed 2025-03-14 |
| 2024-11-14 | 12.09M shares 10-Q · filed 2024-11-14 |
| 2024-08-14 | 10.89M shares 10-Q · filed 2024-08-14 |
| 2024-05-14 | 10.70M shares 10-Q · filed 2024-05-14 |
| 2024-04-29 | 10.56M shares 10-K/A · filed 2024-04-29 |
| 2024-03-25 | 95.70M shares 10-K · filed 2024-03-29 |
| 2023-11-13 | 83.92M shares 10-Q · filed 2023-11-14 |
| 2023-08-09 | 81.70M shares 10-Q · filed 2023-08-14 |
| 2023-05-26 | 70.31M shares 10-K/A · filed 2023-05-26 |
| 2023-05-12 | 70.31M shares 10-Q · filed 2023-05-15 |
| 2023-04-27 | 71.56M shares 10-K/A · filed 2023-05-01 |
| 2023-03-29 | 71.56M shares 10-K · filed 2023-03-31 |
| 2022-11-13 | 67.64M shares 10-Q · filed 2022-11-14 |
| 2022-08-12 | 67.64M shares 10-Q · filed 2022-08-15 |
| 2022-05-11 | 66.64M shares 10-Q · filed 2022-05-16 |
| 2022-03-24 | 66.64M shares 10-K/A · filed 2022-04-29 |
| 2021-11-12 | 58.81M shares 10-Q/A · filed 2022-08-12 |
| 2021-08-16 | 48.60M shares 10-Q/A · filed 2022-08-12 |
| 2021-05-17 | 2.69M shares 10-Q · filed 2021-05-21 |
| 2021-05-07 | 2.69M shares 10-K/A · filed 2021-05-14 |
| 2021-03-30 | 2.69M shares 10-K · filed 2021-04-01 |
| 2020-11-16 | 2.69M shares 10-Q · filed 2020-11-16 |
| 2020-08-12 | 2.69M shares 10-Q · filed 2020-08-14 |
| 2020-05-05 | 2.72M shares 10-Q · filed 2020-05-15 |
| 2019-12-31 | 2.72M shares 10-K · filed 2020-03-30 |
| 2019-11-08 | 6.07M shares 10-Q · filed 2019-11-14 |
| 2019-08-08 | 6.92M shares 10-Q · filed 2019-08-14 |
| 2019-05-15 | 9.04M shares 10-Q · filed 2019-05-15 |
| 2019-03-14 | 9.04M shares 10-K · filed 2019-03-15 |
| 2018-11-07 | 9.04M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 9.04M shares 10-Q · filed 2018-08-08 |
| 2018-05-14 | 9.04M shares 10-Q · filed 2018-05-15 |
| 2018-03-21 | 9.04M shares 10-K · filed 2018-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |